FDA Under a Biden Administration—What Has Happened So Far, and What Can We Expect?

Time: 2:00-3:30 PM ET

Difficulty: Intermediate

Overview: Join us for a panel session that will provide insights into the Biden administration’s FDA during the first eleven months. Panelists will provide perspectives on policies, initiatives, and potential changes at FDA that may affect product development, approvals and enforcement. Topics will include new guidance documents, digital health initiatives, priorities for the directors of CDER, CBER and CDRH, the pandemic and its short-term and long-term effects on the agency, and more!

Speaker Information: